Challenges and impact of biosimilars in value-based cancer care
Whereas several European countries have achieved significant cost savings through greater use of biosimilars , this has yet to be fully realized in the US . An understanding of the origin of the barriers to implementation and potential solutions would ultimately lead to more equitable cancer care for patients in the US
Sandra Cuellar PharmD BCOP UIC College of Pharmacy , University of Illinois , Chicago , IL , USA
18 | 2021 | hospitalpharmacyeurope . com